1. Efficient targeted integration directed by short homology in zebrafish and mammalian cells.
- Author
-
Wierson WA, Welker JM, Almeida MP, Mann CM, Webster DA, Torrie ME, Weiss TJ, Kambakam S, Vollbrecht MK, Lan M, McKeighan KC, Levey J, Ming Z, Wehmeier A, Mikelson CS, Haltom JA, Kwan KM, Chien CB, Balciunas D, Ekker SC, Clark KJ, Webber BR, Moriarity BS, Solin SL, Carlson DF, Dobbs DL, McGrail M, and Essner J
- Subjects
- Animals, Animals, Genetically Modified, CRISPR-Associated Proteins metabolism, Fibroblasts metabolism, Gene Expression Regulation, Green Fluorescent Proteins metabolism, Humans, K562 Cells, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism, RNA, Guide, CRISPR-Cas Systems genetics, RNA, Guide, CRISPR-Cas Systems metabolism, Recombinational DNA Repair, Sequence Homology, Nucleic Acid, Sus scrofa, Transcription Activator-Like Effector Nucleases metabolism, CRISPR-Associated Proteins genetics, CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Knock-In Techniques, Genes, Reporter, Green Fluorescent Proteins genetics, Transcription Activator-Like Effector Nucleases genetics, Zebrafish genetics
- Abstract
Efficient precision genome engineering requires high frequency and specificity of integration at the genomic target site. Here, we describe a set of resources to streamline reporter gene knock-ins in zebrafish and demonstrate the broader utility of the method in mammalian cells. Our approach uses short homology of 24-48 bp to drive targeted integration of DNA reporter cassettes by homology-mediated end joining (HMEJ) at high frequency at a double strand break in the targeted gene. Our vector series, pGTag (plasmids for Gene Tagging), contains reporters flanked by a universal CRISPR sgRNA sequence which enables in vivo liberation of the homology arms. We observed high rates of germline transmission (22-100%) for targeted knock-ins at eight zebrafish loci and efficient integration at safe harbor loci in porcine and human cells. Our system provides a straightforward and cost-effective approach for high efficiency gene targeting applications in CRISPR and TALEN compatible systems., Competing Interests: WW Interests in Lifengine and Lifengine Animal Health, JW, MA, CM, MT, TW, SK, MV, ML, KM, JL, ZM, AW, CM, JH, KK, CC, DB, BW, BM, DD, MM No competing interests declared, DW, SS, DC Shares in Recombinetics, Inc, SE Shares in Lifengine, and Lifengine Animal Health, KC Shares in Recombinetics, Inc, Lifengine and Lifengine Animal Health, JE JJE has a financial conflict of interest with Recombinetics, Inc; Immusoft, Inc; LifEngine and LifEngine Animal Technologies;, (© 2020, Wierson et al.)
- Published
- 2020
- Full Text
- View/download PDF